 |
Radiotracers for Imaging Cannabinoid Sub-Type1 (CB1) Receptor
The present invention relates to novel radiolabeled compounds for imaging cannabinoid sub-type 1 (CB1) receptors in brains of mammals, particularly humans, using positron emission tomography (PET) or single photon emission computed tomography (SPECT). These radioligands can be used in clinical research, diagnostics, or drug discovery and development, More...
View all Featured Technologies
|